Brokerages Set HealthEquity, Inc. (NASDAQ:HQY) PT at $118.09

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned a consensus rating of “Buy” from the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $118.09.

HQY has been the subject of a number of research reports. KeyCorp cut their target price on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a research report on Wednesday, April 16th. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Friday, June 6th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HealthEquity from $98.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, June 5th. The Goldman Sachs Group lifted their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 4th. Finally, Bank of America lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock a “buy” rating in a research report on Wednesday, June 4th.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director directly owned 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the business’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company’s stock, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 295,700 shares of company stock worth $32,968,990. 1.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors have recently bought and sold shares of the stock. Versant Capital Management Inc purchased a new stake in HealthEquity during the first quarter worth approximately $28,000. WPG Advisers LLC purchased a new stake in HealthEquity during the first quarter worth approximately $28,000. Transce3nd LLC purchased a new stake in HealthEquity during the fourth quarter worth approximately $29,000. Smartleaf Asset Management LLC grew its stake in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the period. Finally, Proficio Capital Partners LLC purchased a new stake in HealthEquity during the fourth quarter worth approximately $39,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Down 1.7%

Shares of NASDAQ HQY opened at $99.55 on Friday. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity has a 52 week low of $65.01 and a 52 week high of $116.65. The firm has a 50-day moving average price of $99.74 and a 200 day moving average price of $98.29. The stock has a market capitalization of $8.61 billion, a price-to-earnings ratio of 72.66, a price-to-earnings-growth ratio of 1.57 and a beta of 0.49.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to analysts’ expectations of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same quarter in the previous year, the business posted $0.80 earnings per share. Equities research analysts anticipate that HealthEquity will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.